Mass General Brigham’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,957
Closed -$1K 5
2022
Q1
$1K Buy
+20,957
New +$1K ﹤0.01% 5
2021
Q3
Sell
-19,291
Closed -$131K 12
2021
Q2
$131K Buy
+19,291
New +$131K 0.03% 9